Evidence map›Paper›PMID 42599952›Full record

ArticlePLoS neglected tropical diseases2026

Burden of Shigella infection in children under five years living in a peri-urban area of Ouagadougou, Burkina Faso: A community-based cohort study.

Alimatou Héma, Jean Sawadogo, Ben Idriss Soulama, Denise Hien, Amidou Diarra, Samuel S Sermé, Amidou Z Ouédraogo, Issa Nébié, Sophie Houard, Alphonse Ouédraogo and 3 more

Abstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Alimatou HémaGroupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso.ORCID https://orcid.org/0000-0001-5896-4927
Jean SawadogoGroupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso.
Ben Idriss SoulamaGroupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso.
Denise HienGroupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso.
Amidou DiarraGroupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso.
Samuel S SerméGroupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso.
Amidou Z OuédraogoGroupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso.
Issa NébiéGroupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso.
Sophie HouardEuropean Vaccine Initiative (EVI), Heidelberg, Germany.
Alphonse OuédraogoGroupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso.
Alfred B TionoGroupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso.
Mahamoudou SanouUniversité Joseph KI-ZERBO (UJKZ), Ouagadougou, Burkina Faso.
Sodiomon B SirimaGroupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso.ORCID https://orcid.org/0000-0002-0972-4211

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundShigella is a leading cause of childhood diarrheal disease and a priority target for vaccine development, particularly in low-resource settings where its true burden is often underestimated. A clear understanding of local Shigella epidemiology and risk factors is essential for guiding control strategies and vaccine introduction. METHODOLOGY/PRINCIPAL

findingsWe conducted a 12-month longitudinal cohort study enrolling 750 children under five years of age in a peri-urban area of Ouagadougou, Burkina Faso, from December 2020 to March 2021, with follow-up through March 2022. Active and passive surveillance captured both symptomatic and asymptomatic infections. Stool samples (n = 2,401), including 236 from diarrheal episodes, were analyzed by conventional microbiological methods with species confirmation using the BD Phoenix M50 system. Shigella was isolated from 56 incident cases, yielding an incidence rate of 6.8 cases per 1,000 child-months (95% CI: 5.3-8.9). Shigella flexneri predominated (58.9%), followed by S. boydii (23.2%), S. sonnei (14.3%), and S. dysenteriae (3.6%). Incidence among diarrheal cases was 39.2 per 1,000 child-months (95% CI: 24.7-62.2), alongside substantial asymptomatic carriage (4.9 per 1,000 child-months). Shigellosis was strongly associated with diarrhea, predominantly mucoid rather than bloody stools. Young age was a significant predictor, particularly at 12-23 months (aHR = 2.68; 95% CI: 1.11-6.47) and 36-47 months (aHR = 2.81; 95% CI: 1.08-7.33), while use of a public water source was independently protective (aHR = 0.52; 95% CI: 0.29-0.94). CONCLUSIONS/SIGNIFICANCE: This study provides foundational incidence and serotype data for Shigella among young children in peri-urban Burkina Faso, informing future vaccine development and targeted public health interventions. The findings highlight the need to strengthen water, sanitation, and hygiene programs, improve diagnostic capacity, and enhance antimicrobial resistance surveillance to reduce Shigella transmission and impact in this population.

Indexed as

Dysentery, BacillaryShigellaBurkina FasoChild, PreschoolCohort StudiesDiarrheaFecesFemaleHumansIncidenceInfantLongitudinal StudiesMaleRisk FactorsSuburban Population

Identifiers

PMID42599952
PMCPMC13475976

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.